We're wrapping up the Vital Care Annual Franchise Conference at the JW Marriott in Orlando. Don’t forget to visit us before you leave! Thank you for a great conference! #IVinfusion

It is already Day 3 at the Vital Care Annual Franchise Conference, and we are proud to be a Silver Sponsor. Join us in Orlando at the Melinta booth 36 and meet the team that’s always mighty! #IVinfusion

Stop by the Melinta booth 36 at the Vital Care Annual Franchise Conference in Orlando to meet the Melinta team now through January 16th. #IVinfusion

Melinta is proud to be a silver sponsor of the Vital Care Annual Franchise Conference in Orlando, Florida. Today through January 16, visit us in the Melinta booth 36 and meet the team with passion and purpose! #IVInfusion

We're wrapping up the 66th ASH Annual Meeting & Exposition (#ASH2024) in San Diego. Visit booth 1857 before you leave! Thanks for a great conference! #ASH24

We’re happy to be in California at the San Diego Convention Center, participating in #ASH2024. Come to booth 1857 and meet the team that’s always mighty! #ASH24

Day 2 of the American Society of Hematology 2024 Annual Meeting & Exposition (#ASH2024) and we are exhibiting live at booth 1857; join us in San Diego, CA, and meet the Melinta team. #ASH24

Melinta is in San Diego, CA at the 66th ASH Annual Meeting & Exposition (#ASH2024). Visit us in booth 1857 starting today. #ASH24

Melinta will be live at the 66th ASH Annual Meeting & Exposition (#ASH2024)! Join us at the San Diego Convention Center and stop by booth 1857 from December 7th to 10th. #ASH24

We're wrapping up #IDWeek2024 in Los Angeles, CA at the LACC. Don’t forget to visit us before you leave! Thanks for a great conference #IDWeek. Looking forward to next year!

Today is the last day to visit the Melinta team at booth 407 here at #IDWeek in Los Angeles, CA at the LACC from 10 AM – 2 PM. #IDWeek2024

Meet Melinta at #IDWeek and view poster P-1241, "Cefepime Pharmacodynamics Against Pseudomonas aeruginosa Evaluated in a Chemostat Infection Model: Do Generalized Cephalosporin Targets Translate?" at the PKPD Studies session today #IDWeek2024

Join us at #IDWeek and view poster P-1258, "Unlocking Potentials: The Impact of Meropenem, Meropenem-vaborbactam, and Ceftazidime-avibactam in Combatting Carbapenem- Resistant Enterobacter cloacae in Epithelial Lining Fluid and Serum" at the PKPD Studies session today #IDWeek2024

Visit Melinta at #IDWeek and view poster P-1218, "Assessment Of Cefepime-Taniborbactam (FEP-TAN) Transmembrane Clearance (CLTM) In An Ex Vivo Continuous Renal Replacement Therapy (CRRT) Model" at the PKPD Studies session on Friday, October 18th #IDWeek2024

Please join us at #IDWeek and view poster P-1034, "Week One Outcomes of Rezafungin vs Caspofungin Treatment for Candidemia and Invasive Candidiasis (CIC): Pooled Analysis of Two Randomized Trials Exploring Optimal Echinocandin Duration" at the Medical Mycology session #IDWeek2024

View poster P-1521, "Susceptibility Of Carbapenem-Resistant Enterobacterales (CRE) And Carbapenem-Resistant Pseudomonas Aeruginosa (CRPA) With And Without Carbapenemases To Cefepime-taniborbactam And Comparators: GEARS Antimicrobial Surveillance Program, United States, 2018-2022"

Meet the Melinta team that’s always mighty at #IDWeek booth 407 in Los Angeles, CA at the LACC, now through October 19th. #IDWeek2024

Join us at #IDWeek Session 209, Room 403B 3:45 – 4 PM, "Population Pharmacokinetics of Meropenem-Vaborbactam In Acutely Ill Hospitalized Patients With Various Degrees of Renal Dysfunction" at the Analyzing Antibiotics: B-Lactam Therapeutic Drug Monitoring Oral Abstract session

Join Melinta at #IDWeek and view poster P-1095, "Activity of Rezafungin Against Clinical Isolates of Uncommon Species of Candida Spp." at the Novel Agents session on Friday, October 18th #IDWeek2024

Excited for you to join us at #IDWeek and view poster P-735, "Acute Bacterial Skin and Skin Structure Infections: A Comparison of Outpatient One-Hour Infusion Oritavancin and Inpatient Vancomycin Use" at the Skin and Soft Tissue session on Thursday, October 17th #IDWeek2024